177 related articles for article (PubMed ID: 18269635)
1. The role of IGF-I and its binding proteins in the development of type 2 diabetes and cardiovascular disease.
Ezzat VA; Duncan ER; Wheatcroft SB; Kearney MT
Diabetes Obes Metab; 2008 Mar; 10(3):198-211. PubMed ID: 18269635
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
López-Bermejo A; Khosravi J; Fernández-Real JM; Hwa V; Pratt KL; Casamitjana R; Garcia-Gil MM; Rosenfeld RG; Ricart W
Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
[TBL] [Abstract][Full Text] [Related]
3. Role of IGF-1 in glucose regulation and cardiovascular disease.
Abbas A; Grant PJ; Kearney MT
Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1135-49. PubMed ID: 18793116
[TBL] [Abstract][Full Text] [Related]
4. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F
Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
[TBL] [Abstract][Full Text] [Related]
5. [IGFBP-1 and its protective role in the pathogenesis of microangiopathy in type 1 diabetes mellitus].
Krsek M; Prázný M; Skrha J; Justová V; Lacinová Z
Cas Lek Cesk; 2001 Apr; 140(8):234-7. PubMed ID: 11392040
[TBL] [Abstract][Full Text] [Related]
6. IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis.
Wheatcroft SB; Kearney MT
Trends Endocrinol Metab; 2009 May; 20(4):153-62. PubMed ID: 19349193
[TBL] [Abstract][Full Text] [Related]
7. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study.
Petersson U; Ostgren CJ; Brudin L; Brismar K; Nilsson PM
Diabetes Metab; 2009 Jun; 35(3):198-205. PubMed ID: 19297224
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I and its binding proteins in the cardiovascular system.
Delafontaine P
Cardiovasc Res; 1995 Dec; 30(6):825-34. PubMed ID: 8746194
[TBL] [Abstract][Full Text] [Related]
9. Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis.
Frystyk J
Growth Horm IGF Res; 2004 Oct; 14(5):337-75. PubMed ID: 15336229
[TBL] [Abstract][Full Text] [Related]
10. [Microvascular reactivity in type 2 diabetes mellitus and its relation to IGF-I and its binding proteins].
Krsek M; Prázný M; Skrha J; Justová V; Lacinová Z; Haas T
Vnitr Lek; 2003 Jul; 49(7):535-40. PubMed ID: 12931435
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
[TBL] [Abstract][Full Text] [Related]
12. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
Ranke MB
Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
[TBL] [Abstract][Full Text] [Related]
14. Effects of fasting on IGF-I, IGF-II, and IGF-binding protein mRNA concentrations in channel catfish (Ictalurus punctatus).
Peterson BC; Waldbieser GC
Domest Anim Endocrinol; 2009 Aug; 37(2):74-83. PubMed ID: 19446983
[TBL] [Abstract][Full Text] [Related]
15. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels.
Delafontaine P; Song YH; Li Y
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):435-44. PubMed ID: 14604834
[TBL] [Abstract][Full Text] [Related]
16. Involvement of insulin-like growth factor-I in the control of glucose homeostasis.
Clemmons DR
Curr Opin Pharmacol; 2006 Dec; 6(6):620-5. PubMed ID: 17030015
[TBL] [Abstract][Full Text] [Related]
17. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
Campbell RK
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
[TBL] [Abstract][Full Text] [Related]
18. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
Hemmingsen B; Lund SS; Vaag A
Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
[TBL] [Abstract][Full Text] [Related]
19. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
[TBL] [Abstract][Full Text] [Related]
20. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
